✦ LIBER ✦

1205 SVR-12 AMONG G1/4 TREATMENT-NAIVE PATIENTS RECEIVING MERICITABINE IN COMBINATION WITH PEG-IFNa-2A/RBV: INTERIM ANALYSIS FROM THE JUMP-C STUDY

✍ Scribed by Pockros, P.; Jensen, D.; Tsai, N.; Taylor, R.; Ramji, A.; Cooper, C.; Dickson, R.; Tice, A.; Kulkarni, R.; Najera, I.; Vierling, J.; Thommes, J.

Book ID: 123512269
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 98 KB
Volume: 56
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(12)61217-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1213 EFFICACY AND SAFETY OF MERICITABINE

1213 EFFICACY AND SAFETY OF MERICITABINE (MCB) IN COMBINATION WITH PEG-IFNa-2A/RBV IN G1/4 TREATMENT NAIVE HCV PATIENTS: FINAL ANALYSIS FROM THE PROPEL STUDY

✍ Wedemeyer, H.; Jensen, D.; Herring, R.; Ferenci, P.; Ma, M.M.; Zeuzem, S.; Rodri 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 77 KB

1359 FIRST SVR DATA WITH THE NUCLEOSIDE

1359 FIRST SVR DATA WITH THE NUCLEOSIDE ANALOGUE POLYMERASE INHIBITOR MERICITABINE (RG7128) COMBINED WITH PEGINTERFERON/RIBAVIRIN IN TREATMENT-NAIVE HCV G1/4 PATIENTS: INTERIM ANALYSIS FROM THE JUMP-C TRIAL

✍ Pockros, P.; Jensen, D.; Tsai, N.; Taylor, R.M.; Ramji, A.; Cooper, C.; Dickson, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 48 KB